Prevalence of FXIII34L allele carriers among asymptomatic and symptomatic FV Leiden carriers
| . | FXIIIV34L present . | FXIIIV34L absent . | P . |
|---|---|---|---|
| Without VT (n = 145) | 65 (45) | 80 (55) | NA |
| VT (VTE + STP) (n = 168) | 71 (42) | 97 (58) | .68 |
| VTE (DVT + PE) (n = 155) | 89 (57) | 66 (43) | .72 |
| DVT (n = 113) | 63 (56) | 50 (44) | .93 |
| PE (n = 42) | 26 (62) | 16 (38) | .46 |
| . | FXIIIV34L present . | FXIIIV34L absent . | P . |
|---|---|---|---|
| Without VT (n = 145) | 65 (45) | 80 (55) | NA |
| VT (VTE + STP) (n = 168) | 71 (42) | 97 (58) | .68 |
| VTE (DVT + PE) (n = 155) | 89 (57) | 66 (43) | .72 |
| DVT (n = 113) | 63 (56) | 50 (44) | .93 |
| PE (n = 42) | 26 (62) | 16 (38) | .46 |
Numbers of carriers given; percentages are in parentheses.
VT indicates venous thrombosis; VTE, venous thromboembolism; STP, superficial thrombophlebitis; DVT, patients with at least one episode of deep venous thrombosis; and PE, patients with at least one episode of pulmonary embolism associated or not with DVT.